Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
May 22, 2008

Primetech to Sell Seahorse’s XF Technology in Japan

  • Primetech agreed to become the exclusive supplier of Seahorse Bioscience’s XF instruments and consumables in Japan.

    “Our customers are interested in studying mitochondrial dysfunction and in particular its role in cancer, obesity, and age-related diseases,” points out Ryosuke Ogihara, CEO of Primetech. “Seahorse XF instruments offer the only practical way to study mitochondria in whole cells.”

    Introduced in June of 2006, Seahorse extracellular flux (XF) analyzers provide the first and only method to noninvasively measure the two major energy producing pathways, mitochondrial respiration and glycolysis, in living cells, according to Seahorse.